← Browse by Condition
Medical Condition
locally advanced or metastatic solid tumors
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 2
NCT05205109 Phase 1
Recruiting
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
Enrollment
98 pts
Location
Australia, China
Sponsor
Antengene Therapeutics Limited
NCT06244992 Phase 1, Phase 2
Recruiting
PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors
Enrollment
68 pts
Location
United States
Sponsor
Pyrotech Therapeutics, Inc.
NCT07202364 Phase 2
Recruiting
A Study of YL202 in Patients With Advanced Solid Tumors
Enrollment
100 pts
Location
China
Sponsor
MediLink Therapeutics (Suzhou)...
NCT06246071 Phase 1
Recruiting
A Study of TYK-00540 in Adult Patients With Solid Tumors
Enrollment
156 pts
Location
China
Sponsor
TYK Medicines, Inc